CSIMarket



Viewray Inc.  (VRAY)
Other Ticker:  
 

Viewray's Leverage Ratio

VRAY's quarterly Leverage Ratio and Total Liabilities, Equity growth




VRAY Leverage Ratio (Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Equity Change 12.42 % -20.1 % -15.26 % -39.74 % 39.98 %
Y / Y Total Liabilities Change 9.32 % 4.39 % -1 % -1.91 % 8.77 %
Leverage Ratio MRQ 0.9 0.97 0.75 1.01 0.92
Overall Ranking # 892 # 0 # 1984 # 1479 # 1818
Seq. Equity Change 22.11 % -15.42 % 26.21 % -13.75 % -13.21 %
Seq. Total Liabilities Change 12.75 % 9.18 % -5.94 % -5.58 % 7.66 %



Leverage Ratio forth quarter 2021 Comment
In Spite of the net new borrowings of 12.75% Viewray managed to improve Leverage Ratio in the forth quarter 2021 to 0.9, below company's average Leverage Ratio.

Within Medical Equipment & Supplies industry in the forth quarter 2021, 70 other companies have achieved lower Leverage Ratio than Viewray. While Leverage Ratio total ranking has deteriorated compare to the previous quarter from 0 to 892.

Explain Leverage Ratio?
Who are VRAY Customers?
Leverage Ratio forth quarter 2021 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 71
Healthcare Sector # 269
Overall Market # 892


Leverage Ratio Statistics
High Average Low
56.02 4.68 0.59
(Dec 31 2017)   (Sep 30 2018)




Financial Statements
Viewray's Equity $ 170 Millions Visit VRAY's Balance sheet
Viewray's Total Liabilities $ 152 Millions Visit VRAY's Balance sheet
Source of VRAY's Sales Visit VRAY's Sales by Geography


Cumulative Viewray's Leverage Ratio

VRAY's Leverage Ratio for the trailling 12 Months

VRAY Leverage Ratio

(Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Equity TTM Growth 12.42 % -20.1 % -15.26 % -39.74 % 39.98 %
Y / Y Total Liabilities TTM Growth 9.32 % 4.39 % -1 % -1.91 % 8.77 %
Leverage Ratio TTM 0.9 0.9 0.84 0.81 0.72
Total Ranking TTM # 1631 # 0 # 1453 # 768 # 1966
Seq. Equity TTM Growth 22.11 % -15.42 % 26.21 % -13.75 % -13.21 %
Seq. Total Liabilities TTM Growth 12.75 % 9.18 % -5.94 % -5.58 % 7.66 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Despite of the net new borrowings of 12.75% Viewray managed to unchange Leverage Ratio in IV. Quarter to 0.9, below Viewray's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 114 other companies have achieved lower Leverage Ratio than Viewray. While total ranking remained unchanged compare to previous quarter at no. 1631.

Explain Leverage Ratio?
Who are VRAY Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 115
Healthcare Sector # 607
Within the Market # 1631


TTM Leverage Ratio Statistics
High Average Low
29.95 3.12 0.72
(Mar 31 2018)   (Sep 30 2020)




Companies with similar Leverage Ratio in the quarter ending Dec 31 2021, within Medical Equipment & Supplies Industry Leverage RatioDec 31 2021 MRQ Total LiabilitiesDec 31 2021 MRQ Equity
Newegg Commerce Inc   2.44 $ 444.300  Millions$ 182.282  Millions
Hireright Holdings Corp  2.25 $ 1,002.751  Millions$ 445.717  Millions
Venus Concept Inc.  2.13 $ 88.704  Millions$ 41.596  Millions
Avinger Inc  2.03 $ 19.762  Millions$ 9.723  Millions
Star Equity Holdings Inc.  1.93 $ 32.310  Millions$ 16.754  Millions
Msa Safety Inc  1.87 $ 1,562.008  Millions$ 834.388  Millions
Cerus Corporation  1.81 $ 152.880  Millions$ 84.619  Millions
Escalon Medical Corp   1.74 $ 2.998  Millions$ 1.724  Millions
Delcath Systems Inc.  1.72 $ 20.549  Millions$ 11.952  Millions
Alector Inc.  1.71 $ 513.934  Millions$ 300.724  Millions
Nuvasive Inc  1.71 $ 1,358.868  Millions$ 795.207  Millions
Tela Bio Inc.  1.71 $ 34.285  Millions$ 20.098  Millions
Harpoon Therapeutics Inc.  1.68 $ 97.382  Millions$ 58.070  Millions
Patterson Companies Inc.  1.67 $ 1,746.326  Millions$ 1,044.178  Millions
Motus Gi Holdings Inc.  1.67 $ 16.125  Millions$ 9.657  Millions
Minerva Surgical Inc.  1.61 $ 70.988  Millions$ 44.104  Millions
Novocure Limited  1.61 $ 658.999  Millions$ 410.494  Millions
Haemonetics Corp  1.47 $ 1,074.469  Millions$ 730.775  Millions
Artivion Inc.  1.38 $ 414.282  Millions$ 300.728  Millions
Vapotherm Inc.  1.37 $ 91.337  Millions$ 66.667  Millions
Stryker Corp  1.33 $ 19,754.000  Millions$ 14,877.000  Millions
Precision Biosciences Inc  1.32 $ 120.330  Millions$ 91.168  Millions
Cognyte Software Ltd   1.27 $ 379.468  Millions$ 299.089  Millions
Becton Dickinson And Company  1.21 $ 29,203.000  Millions$ 24,160.000  Millions
Biolase Inc.  1.19 $ 30.076  Millions$ 25.208  Millions
Bioventus Inc.  1.19 $ 633.420  Millions$ 533.789  Millions
Pear Therapeutics Inc.  1.18 $ 106.726  Millions$ 90.434  Millions
Conmed Corporation  1.16 $ 912.045  Millions$ 785.435  Millions
Dexcom Inc.  1.11 $ 2,490.900  Millions$ 2,251.500  Millions
Iridex Corp  1.09 $ 25.388  Millions$ 23.299  Millions

Date modified: 2022-08-04T12:59:14-04:00

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WDDN's Profile

Stock Price

WDDN's Financials

Business Description

Fundamentals

Charts & Quotes

WDDN's News

Suppliers

WDDN's Competitors

Customers & Markets

Economic Indicators

WDDN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071